Inserm Transfert

Tweet this page
<
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 03 Apr 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

50,000€ - 99,999€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

0.45 Fte (3)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    Inserm Transfert   (IT)

    EU Transparency Register

    190044226228-01 First registered on 22 Mar 2017

    Goals / Remit

    Private subsidiary of Inserm, Inserm Transfert manages every aspect of the promotion and transfer of knowledge obtained by Inserm’s research laboratories to industry, thereby helping to promote health innovation. Inserm Transfert focus on adding value and minimizing risk for innovative projects at pre-industrial stage, bridging discovery and clinical research. We put emphasis on identifying high-potential projects, implementing appropriate proof of concept and IP strategies, and setting up win-win/mutually beneficial industrial partnerships.

    Main EU files targeted

    EU legislatives proposals or policies pertaining to
    - Pharmaceutical regulation and medicinal product marketing authorisation,
    - Research and innovation,
    - Public health (both human and animal and digital health data)

    Address

    Head Office
    10 rue d'Oradour-sur-Glane
    Paris 75015
    FRANCE
    EU Office
    10 rue d'Oradour-sur-Glane
    Paris 75015
    FRANCE

    Website

    http://www.inserm-transfert.fr

  • People

    Total lobbyists declared

    3

    Employment timeLobbyists
    25%1

    Lobbyists (Full time equivalent)

    0.45

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    Our involvement begins (with INSERM), by raising topics that can be subject of a topic in the various EU work programs thanks to the French representative at the EU committee program, with the contribution of Catherine Clusel - Director of the Collaborative Research funding department (25%)

    Our CEO Pascale Augé and Sandrine Ayuso - chief of staff - (10% each) act as Inserm Transfert representatives at national, european and international level.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    Inserm Transfert is a member of the
    - Reseau C.U.R.I.E https://www.curie.asso.fr/reseau-curie/qui-sommes-nous/administrateurs

    - Association France Biotech https://france-biotech.fr/annuaire/?_annuaire=adherents&_company_name=Inserm%20Transfert

    - Pascale Augé our CEO is a membre of the network AUTM-Association of University Technology Managers https://autm.net/

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    50,000€ - 99,999€

    Major contributions in closed year

    TypeNameAmount
    Grant Cardiateam Project IMI2-2017-13-01 86,551€
    Grant CARE Project IMI2 call 21 coronavirus 61,460€
    Grant CCH Vaccine H2020 SC1-PM-06-2016 32,000€
    Grant FAIR H2020-SC1-BHC-14-2019 42,291€
    Grant IP-Cure-B Project H2020-SC1-BHC-14-2019 81,210€
    Grant JPsustaiND Project H2020-HCO-2015 91,327€
    Grant MAD-CoV 2 Project IMI2-2020-21-01 54,870€
    Grant MEDIT-AGEING Project H2020-PHC-2015 33,376€
    Grant miniNO Project SC1-BHC-01-2019 93,976€
    Grant MIROCALS Project H2020-PHC-2014-two-stage 54,976€
    Grant R-LiNK Project SC1-PM-02-2017 9,314€
    Grant THERALYMPH Project H2020 SC1-BHC-07-2019 37,182€
    Grant VHFMODRAD Project IMI2-2015-08 12,750€
    Grant EJP-RD Project SC1-BHC-04-2018 104,033€
    Grant RITA-MI2 Project H2020-SC1-BHC-2018-2020 93,008€
    Grant CBIG-SCREEN Project H2020-SC1-BHC-2018-2020 73,195€
    Grant BE READY Project HORIZON-HLTH-2021-DISEASE-04 148,781€
    Grant MPX-RESPONSE Project HORIZON-HLTH-2022-MPX-14-01 117,293€
    Grant HT Advance Project HORIZON-HLTH-2022-TOOL-11-01 323,487€
    Grant CARE IN HEALTH Project HORIZON-HLTH-2022-STAYHLTH-02-01 153,343€
    Grant OBELISK Project HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage 179,463€
    Grant MITI2 Project HORIZON-HLTH-2022-DISEASE-06-02-two-stage 226,152€
    Grant ARTiDe Project HORIZON-HLTH-2022-DISEASE-06-two-stage 123,244€

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    50,000€ - 99,999€

    Other financial info

    EU grants that contribute to the operating costs
    - We have a department dedicated to project management of EC projects. This department is made up of 25 people namely- Collaborative Research Funding - entirely dedicated since 2003 to support researchers in handling project management and reporting to European Commission. During the most recent closed financial year (2023) our company was a full partner of 34 EU funding projects and recevied prepayment for 23 projects.

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    N/A

    Communication activities

    None declared

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard